Login / Signup

Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.

Ahilanandan DushianthanHoward ClarkJens MadsenRobin MoggLewis MatthewsLee BerryJorge Bernardino de la SernaJames BatchelorDavid BrealeyTracy HussellJoanna PorterRatko DjukanovicMartin FeelischAnthony PostleMichael P W Grocott
Published in: Trials (2020)
ClinicalTrials.gov: NCT04362059 (Registered 24 April 2020), EUDAMED number: CIV-GB-20-06-033328, EudraCT number: 2020-001886-35 (Registered 11 May 2020) FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol. The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines (Additional file 2).
Keyphrases
  • randomized controlled trial
  • sars cov
  • study protocol
  • coronavirus disease
  • clinical trial
  • clinical practice
  • respiratory syndrome coronavirus
  • double blind
  • drug induced